Raymond David Eugene Dupuis - Net Worth and Insider Trading

Raymond David Eugene Dupuis Net Worth

The estimated net worth of Raymond David Eugene Dupuis is at least $98,540 dollars as of 2024-11-11. Raymond David Eugene Dupuis is the Senior Officer of Kane Biotech Inc and owns about 985,404 shares of Kane Biotech Inc (TSXV:KNE) stock worth over $98,540. Details can be seen in Raymond David Eugene Dupuis's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raymond David Eugene Dupuis has not made any transactions after 2023-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Raymond David Eugene Dupuis

To

Raymond David Eugene Dupuis Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Raymond David Eugene Dupuis owns 1 companies in total, including Kane Biotech Inc (TSXV:KNE) .

Click here to see the complete history of Raymond David Eugene Dupuis’s form 4 insider trades.

Insider Ownership Summary of Raymond David Eugene Dupuis

Ticker Comapny Transaction Date Type of Owner
TSXV:KNE Kane Biotech Inc 2023-09-11 Senior Officer

Raymond David Eugene Dupuis Latest Holdings Summary

Raymond David Eugene Dupuis currently owns a total of 1 stock. Raymond David Eugene Dupuis owns 985,404 shares of Kane Biotech Inc (TSXV:KNE) as of September 11, 2023, with a value of $98,540.

Latest Holdings of Raymond David Eugene Dupuis

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSXV:KNE Kane Biotech Inc 2023-09-11 985,404 0.10 98,540

Holding Weightings of Raymond David Eugene Dupuis


Raymond David Eugene Dupuis Form 4 Trading Tracker

According to the SEC Form 4 filings, Raymond David Eugene Dupuis has made a total of 3 transactions in Kane Biotech Inc (TSXV:KNE) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Kane Biotech Inc is the acquisition of 125,000 shares on September 11, 2023, which cost Raymond David Eugene Dupuis around $10,000.

Insider Trading History of Raymond David Eugene Dupuis

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Raymond David Eugene Dupuis Trading Performance

GuruFocus tracks the stock performance after each of Raymond David Eugene Dupuis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Raymond David Eugene Dupuis is -15.97%. GuruFocus also compares Raymond David Eugene Dupuis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Raymond David Eugene Dupuis within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Raymond David Eugene Dupuis's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Raymond David Eugene Dupuis

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.5 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -11.37 LIMIT LIMIT LIMIT LIMIT LIMIT

Raymond David Eugene Dupuis Ownership Network

Ownership Network List of Raymond David Eugene Dupuis

No Data

Ownership Network Relation of Raymond David Eugene Dupuis

Insider Network Chart

Raymond David Eugene Dupuis Owned Company Details

What does Kane Biotech Inc do?

Who are the key executives at Kane Biotech Inc?

Raymond David Eugene Dupuis is the Senior Officer of Kane Biotech Inc. Other key executives at Kane Biotech Inc include and 10% Security Holder Richard J. Renaud .

Kane Biotech Inc (TSXV:KNE) Insider Trades Summary

Over the past 18 months, Raymond David Eugene Dupuis made 1 insider transaction in Kane Biotech Inc (TSXV:KNE) with a net purchase of 125,000. Other recent insider transactions involving Kane Biotech Inc (TSXV:KNE) include a net purchase of 275,000 shares made by Marc Edwards , a net purchase of 3,125,000 shares made by Richard J. Renaud , and a net sale of 2,000,000 shares made by Philip Renaud .

In summary, during the past 3 months, insiders sold 0 shares of Kane Biotech Inc (TSXV:KNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,000,000 shares of Kane Biotech Inc (TSXV:KNE) were sold and 3,525,000 shares were bought by its insiders, resulting in a net purchase of 1,525,000 shares.

Kane Biotech Inc (TSXV:KNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kane Biotech Inc Insider Transactions

No Available Data

Raymond David Eugene Dupuis Mailing Address

Above is the net worth, insider trading, and ownership report for Raymond David Eugene Dupuis. Currently GuruFocus does not have mailing address information for Raymond David Eugene Dupuis.